Cellebrite DI Ltd. Form 6-K Summary
Business Context and Reporting Period
Cellebrite DI Ltd., a foreign private issuer based in Petah Tikva, Israel, filed this Form 6-K on February 11, 2026. The filing serves to disseminate a press release announcing record financial results for the fourth quarter and full year of 2025.
Key Financial Metrics
The filing text references a press release containing GAAP financial statements but does not explicitly list specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity within the provided document body. The filing states that these tables are incorporated by reference into prior registration statements (Forms S-8 and F-3) and are furnished as Exhibit 99.1.
Material Changes
Management announced record results for the fourth quarter and full year 2025. Specific quantitative comparisons to prior periods are not detailed in the filing text itself.
Guidance, Outlook, and Risks
The filing text does not contain specific guidance, outlook figures, management commentary, risk factors, or details on contingencies and unusual items. These details are contained within the attached press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for Q4 and Full Year 2025.
- Verify the year-over-year growth rates cited in the "record results" announcement.
- Check the incorporated GAAP tables in Forms S-8 and F-3 for detailed financial breakdowns.
- Confirm any forward-looking guidance or updated risk factors mentioned in the full press release.